A randomized, double-blind, placebo-controlled, single center study designed to assess the effects of pregabalin on change in patients with diabetic neuropathy

Trial Profile

A randomized, double-blind, placebo-controlled, single center study designed to assess the effects of pregabalin on change in patients with diabetic neuropathy

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2014

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top